These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1003712)

  • 1. Effects of thyroidectomy on amphetamine-induced acceleration of locomotor activity in mice.
    Ohashi K; Tadokoro S
    Jpn J Pharmacol; 1976 Oct; 26(5):621-4. PubMed ID: 1003712
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the effects of D-amphetamine and L-amphetamine in reversing depression of mouse locomotor activity caused by reserpine.
    Proctor CD; Kirby J; Wood MH; Wade LH; King PK
    Arch Int Pharmacodyn Ther; 1974 Nov; 212(1):108-15. PubMed ID: 4451411
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of scopolamine and d-amphetamine on locomotor activity before and after shock: a diallel analysis in mice.
    Anisman H
    Psychopharmacology (Berl); 1976 Jul; 48(2):165-73. PubMed ID: 826929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rate-dependent effects of d-amphetamine on locomotor activity in mice: possible relationship to paradoxical amphetamine sedation in minimal brain dysfunction.
    Glick SD; Milloy S
    Eur J Pharmacol; 1973 Nov; 24(2):266-8. PubMed ID: 4797286
    [No Abstract]   [Full Text] [Related]  

  • 5. Heat production and heat loss in d-amphetamine hyperthermia in aggregated Swiss Webster and BDF mice.
    Craigmill AL; Kupferberg HJ; Miller JW
    Toxicol Appl Pharmacol; 1973 Nov; 26(3):362-9. PubMed ID: 4767574
    [No Abstract]   [Full Text] [Related]  

  • 6. Differential effects of d- and 1-amphetamine on spontaneous motor activity in mice.
    Maickel RP; Levine RM; Quirce CM
    Res Commun Chem Pathol Pharmacol; 1974 Aug; 8(4):711-4. PubMed ID: 4420179
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypermotility of the amphetamine type induced by a constituent of khat leaves.
    Kalix P
    Br J Pharmacol; 1980 Jan; 68(1):11-3. PubMed ID: 7357134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a selective brain noradrenergic involvement in the locomotor stimulant effects of amphetamine in the rat.
    Ogren SO; Archer T; Johansson C
    Neurosci Lett; 1983 Dec; 43(2-3):327-31. PubMed ID: 6687006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of d-amphetamine upon open field behaviour in two inbred strains of mice.
    Moisset B; Welch BL
    Experientia; 1973 May; 29(5):625-6. PubMed ID: 4730313
    [No Abstract]   [Full Text] [Related]  

  • 10. Stimulation of locomotor activity of genetically obese mice by amphetamine.
    Yen TT; Acton JM
    Experientia; 1973 Oct; 29(10):1297-8. PubMed ID: 4758947
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison between locomotor activity changes produced by phencyclidine and D-amphetamine in CD-1 male mice.
    Stavchansky S; Riffee W; Geary R
    Res Commun Chem Pathol Pharmacol; 1985 May; 48(2):189-202. PubMed ID: 4023408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the substantia nigra in the locomotor stimulant action of amphetamine.
    Costall B; Naylor RJ
    Br J Pharmacol; 1973 Sep; 49(1):29-36. PubMed ID: 4787564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic amphetamine administration and central dopamine receptor sensitivity [proceedings].
    Jenner P; Marsden CD; Pycock CJ
    Br J Pharmacol; 1977 Sep; 61(1):142P. PubMed ID: 912190
    [No Abstract]   [Full Text] [Related]  

  • 14. Differential effects of neuroleptic drugs on amphetamine-induced stimulation of locomotor activity in 11-day-old and adult rats.
    Miller R; Sahakian B
    Brain Res; 1974 Dec; 81(2):387-92. PubMed ID: 4154799
    [No Abstract]   [Full Text] [Related]  

  • 15. Conditioned drug effects to d-amphetamine- and morphine-induced motor acceleration in mice: experimental approach for placebo effect.
    Hayashi T; Ohashi K; Tadokoro S
    Jpn J Pharmacol; 1980 Feb; 30(1):93-100. PubMed ID: 7401412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of d-amphetamine and scopolamine on activity before and after shock in three mouse strains.
    Anisman H; Wahlsten D; Kokkinidis L
    Pharmacol Biochem Behav; 1975; 3(5):819-24. PubMed ID: 1208622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amphetamine increases activity but not exploration in humans and mice.
    Minassian A; Young JW; Cope ZA; Henry BL; Geyer MA; Perry W
    Psychopharmacology (Berl); 2016 Jan; 233(2):225-33. PubMed ID: 26449721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcitonin depresses amphetamine-induced locomotor activity.
    Twery MJ; Cooper CW; Mailman RB
    Pharmacol Biochem Behav; 1983 Jun; 18(6):857-62. PubMed ID: 6889413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of the central effects of d-amphetamine by amantadine. II.
    Prepas S; Menon MK; Clark WG
    Arzneimittelforschung; 1975 May; 25(5):780-2. PubMed ID: 1242323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of lead, d-amphetamine, and time of day on activity levels in the mouse.
    Dolinsky Z; Fink E; Burright RG; Donovick PJ
    Pharmacol Biochem Behav; 1981 Jun; 14(6):877-80. PubMed ID: 7255522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.